close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Michael Hinni

location-icon

Phoenix, AZ

LOCATION OF PRACTICE
Mayo Clinic Hospital
MEDICAL Specialty:

And Neck, Face, Oral Cancer, Soft Tissue Sarcoma Of Head, Tongue Cancer



5779 E MAYO BLVD, PHOENIX, AZ, 850544502
5779 E MAYO BLVD, PHOENIX, AZ, 850544502
480-301-8000
NPI Number
1073598736
ABOUT

Michael Hinni, MD, is a Head & Neck Surgical Oncology Specialist in Mayo Clinic in Phoenix, AZ. He frequently treats conditions such as Oral Cancer, Tongue Cancer, and Soft Tissue Sarcoma of the Head, Face, and Neck. Hinni completed a fellowship at University Hospital.

Dr. Michael Hinni profile image

Published Articles

De-Escalated Adjuvant Radiation Therapy in Patients With HPV-Positive Oropharyngeal Cancer.- 2026 May 1
Improving Intraoperative Parathyroid Hormone Monitoring with a Multidisciplinary Checklist: A Quality Improvement Initiative.- 2026 Feb
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study.- 2025 Oct
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial.- 2025 Sep
Pancreatic Polypeptide Secretory Paraganglioma Successfully Treated With Radiosurgery Resulting in Elimination of Life-Debilitating Diarrhea.- 2025 Oct
Extracorporeal Membrane Oxygen Assisted Intubation for Complex Airways.- 2025 Aug 20
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.- 2025 Jul 1
Identification of clinical and pathologic features associated with extranodal extension in patients with HPV-mediated oropharyngeal squamous cell carcinoma.- 2025 Jul
What is the Optimal Anticoagulation in HGNS Surgery in Patients with High-risk Cardiac Comorbidities?- 2025 Apr
Total Laryngeal Transplant in the Setting of Active Laryngeal Malignancy.- 2024 Sep

Other Specialists treating and Neck, Face, Oral Cancer, Soft Tissue Sarcoma of Head, Tongue Cancer in Phoenix, AZ

See All Doctors

Dr. Devyani Lal

Specialty: Soft Tissue Sarcoma of Head, Face, and Neck, Malignant Bone Cancer of the Skull, Face, and Jaw, Acute Sinusitis

My Resources
location-icon

Mayo Clinic Hospital

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider